1
|
Mariano L, Nicosia L, Bozzini A, Pesapane F, Magnoni F, Mazzarol G, Meneghetti L, Sorce A, Cassano E. Case report: Illustrating associated malignancies in Paget's disease using contrast-enhanced mammography. Front Oncol 2025; 14:1497506. [PMID: 39845319 PMCID: PMC11751236 DOI: 10.3389/fonc.2024.1497506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2024] [Accepted: 12/17/2024] [Indexed: 01/24/2025] Open
Abstract
Introduction The following presentation explores the diagnostic potential of Contrast-Enhanced Mammography (CEM) in evaluating and managing Paget's Disease (PD) of the breast, particularly as an alternative or complementary tool to Magnetic Resonance Imaging (MRI) in cases where MRI is contraindicated or inconclusive. Clinical cases Two clinical cases of PD diagnosed at our Breast Imaging Division between January and May 2024 were analyzed using CEM. These cases involved imaging techniques, including Digital Mammography (DM), Breast Ultrasound (US), MRI and CEM, alongside histopathological confirmation through nipple-areolar complex (NAC) punch biopsies. CEM identified disease extensions and NAC involvement that was not evident in conventional imaging in both cases. CEM findings influenced surgical decisions, leading to total mastectomies with reconstruction instead of conservative approaches. The cases highlighted CEM's sensitivity and ability to delineate the disease extent comparable to MRI. Discussion and conclusions PD often presents diagnostic challenges due to frequent associations with underlying malignancies that are undetectable by standard imaging. While MRI is the gold standard, its limitations, such as costs, contraindications, and false positives, warrant alternative methods. CEM demonstrated utility in diagnosing and staging PD, offering benefits in patient acceptability, cost, and sensitivity comparable to MRI. CEM is a promising diagnostic and planning tool for PD management, especially in MRI-infeasible cases. More extensive multicentric studies will be needed to validate CEM's role in this context. CEM could enhance PD diagnostic workflows and treatment strategies, significantly impacting clinical outcomes.
Collapse
Affiliation(s)
- Luciano Mariano
- Breast Imaging Division, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy
| | - Luca Nicosia
- Breast Imaging Division, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy
- Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy
| | - Anna Bozzini
- Breast Imaging Division, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy
| | - Filippo Pesapane
- Breast Imaging Division, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy
| | - Francesca Magnoni
- Division of Breast Surgery, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy
| | - Giovanni Mazzarol
- Division of Pathology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy
| | - Lorenza Meneghetti
- Breast Imaging Division, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy
| | - Adriana Sorce
- Postgraduation School in Radiodiagnostics, Università degli Studi di Milano, Milan, Italy
| | - Enrico Cassano
- Breast Imaging Division, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy
| |
Collapse
|
2
|
Sivarajah RT, Bean TR, Chetlen AL. Diffuse unilateral MRI breast entities. Clin Imaging 2024; 115:110305. [PMID: 39342818 DOI: 10.1016/j.clinimag.2024.110305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2024] [Revised: 09/16/2024] [Accepted: 09/19/2024] [Indexed: 10/01/2024]
Abstract
Many benign and malignant breast entities can present with diffuse unilateral magnetic resonance imaging (MRI) findings. The unilateral breast findings can be broken down into three broad categories including asymmetric diffuse masses/non-mass enhancement (NME), diffuse unilateral skin thickening, and diffuse asymmetric background enhancement. Although correlation with clinical history is always necessary, biopsy is often needed to make a definitive diagnosis. There are some findings on MRI which can help narrow the differential including morphology, distribution, T2W signal, enhancement kinetics, and associated skin thickening. Malignant entities which will be discussed in this review include ductal carcinoma in situ, invasive ductal carcinoma, invasive lobular carcinoma, Paget disease, inflammatory breast cancer, and locally advanced breast cancer. Benign entities which will be discussed in this review include idiopathic granulomatous mastitis (IGM), infectious mastitis, pseudoangiomatous stromal hyperplasia, giant fibroadenoma, early and late radiation changes, unilateral breast feeding, and central venous obstruction, all which have varied MRI appearances. It is important for radiologists to be familiar with the common entities that can present with diffuse asymmetric unilateral MRI breast findings to ensure the correct diagnosis and management is undertaken.
Collapse
Affiliation(s)
- Rebecca T Sivarajah
- Department of Radiology, Penn State Health, Hershey Medical Center, 30 Hope Drive, EC 008, Breast Center, Hershey, PA 17033, United States of America.
| | - Trevor R Bean
- Penn State College of Medicine, 700 HMC Crescent Road, Hershey, PA 17033, United States of America.
| | - Alison L Chetlen
- Department of Radiology, Penn State Health, Hershey Medical Center, 30 Hope Drive, EC 008, Breast Center, Hershey, PA 17033, United States of America.
| |
Collapse
|
3
|
Scott-Emuakpor R, Reza-Soltani S, Altaf S, Nr K, Kołodziej F, Sil-Zavaleta S, Nalla M, Ullah MN, Qureshi MR, Ahmadi Y, Rezvani A, Siddiqui HF. Mammary Paget's Disease Mimicking Benign and Malignant Dermatological Conditions: Clinical Challenges and Diagnostic Considerations. Cureus 2024; 16:e65378. [PMID: 39188449 PMCID: PMC11346752 DOI: 10.7759/cureus.65378] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/25/2024] [Indexed: 08/28/2024] Open
Abstract
Mammary Paget's disease (MPD) or Paget's disease of the breast is a rare dermatological malignancy of the nipple-areolar complex that manifests with a spectrum of symptoms spanning from itching and redness to more severe indications such as breast lump, nipple-areolar complex destruction, or nipple discharge. It is predominantly associated with an underlying ductal carcinoma in situ or invasive ductal carcinoma. MPD often masquerades as other benign and malignant dermatological conditions, including eczema, atopic dermatitis, psoriasis, and squamous and basal cell carcinomas, leading to delayed diagnosis and inappropriate treatment. Only one-third of the patients present with a palpable lump; therefore, advanced age with chronic and unilateral lesions should raise concern for MPD. Our review article presents case reports of MPD imitating other skin conditions and underscores the key findings of clinical features and diagnostic workup to help differentiate the condition. A literature review revealed that studies emphasize caution regarding the sole use of mammography and ultrasound in diagnosing MPD, particularly in cases lacking a palpable lump. This highlights the MRI as a superior and more accurate imaging tool. However, any suspicious lesion must be biopsied to allow histopathological and immunohistochemical examination, since there are some cases where MRI findings were negative in the presence of a biopsy-proven MPD. This highlights the need for clinicians to investigate any suspicious lesion of the nipple or breast using the complete triple assessment approach to exclude an underlying malignancy. It is imperative to establish therapeutic guidelines to approach any nipple lesion to minimize the risk of misdiagnosing any underlying cancer, which can be potentially fatal if left alone.
Collapse
Affiliation(s)
| | - Setareh Reza-Soltani
- Advanced Diagnostic and Interventional Radiology Center (ADIR), Tehran University of Medical Sciences, Tehran, IRN
| | - Sana Altaf
- Internal Medicine, Deccan College of Medical Sciences, Hyderabad, IND
| | - Kaushik Nr
- General Medicine, Rajiv Gandhi Government General Hospital, Chennai, IND
| | | | - Susana Sil-Zavaleta
- Dermatology, Universidad Anahuac, México City, MEX
- Dermatology, Hospital Ángeles del Pedregal, México City, MEX
| | - Monica Nalla
- Surgery, Rajiv Gandhi University of Health Sciences, Bengaluru, IND
| | | | | | - Yasmin Ahmadi
- Medicine, Royal College of Surgeons in Ireland - Medical University of Bahrain, Muharraq, BHR
| | - Ali Rezvani
- Anesthesiology, Case Western Reserve University School of Medicine, Cleveland, USA
| | - Humza F Siddiqui
- Internal Medicine, Jinnah Sindh Medical University, Karachi, PAK
| |
Collapse
|
4
|
Chen P, Ho Y, Chen C, Chiu C. Invasive cribriform carcinoma of the breast presenting as an erythematous papule on the nipple: A case report. Clin Case Rep 2024; 12:e9055. [PMID: 38840754 PMCID: PMC11150131 DOI: 10.1002/ccr3.9055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2024] [Revised: 05/20/2024] [Accepted: 05/27/2024] [Indexed: 06/07/2024] Open
Abstract
Invasive cribriform carcinoma (ICC) is a rare form of invasive breast carcinoma with good prognosis. To date, case reports considering skin manifestations of ICC are scarce. We herein report a case of pure ICC presenting as an erythematous papule on the nipple with mammary Paget's disease in the epidermis. We aim to bring awareness to skin manifestation of ICC.
Collapse
Affiliation(s)
- Po‐Yu Chen
- Department of Medical EducationTaichung Veterans General HospitalTaichungTaiwan
| | - Yu‐Hsuan Ho
- Department of DermatologyTaichung Veterans General HospitalTaichungTaiwan
| | - Chih‐Jung Chen
- Department of Pathology and Laboratory MedicineTaichung Veterans General HospitalTaichungTaiwan
| | - Chien‐Shan Chiu
- Department of DermatologyTaichung Veterans General HospitalTaichungTaiwan
| |
Collapse
|
5
|
Afzal RJ, Basree MM, Howard SP, Xu J, Wilke LG, Anderson BM. Mammary Paget's Disease as a Sign of Local Recurrence Two Decades Following Breast Conservation and Adjuvant Therapy for Early Stage Breast Cancer. Cureus 2024; 16:e61521. [PMID: 38957233 PMCID: PMC11218596 DOI: 10.7759/cureus.61521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2024] [Accepted: 06/02/2024] [Indexed: 07/04/2024] Open
Abstract
Reports of mammary Paget's disease (MPD) as a manifestation of breast cancer recurrence are rare. MPD presents a particular challenge when emerging more than two decades after a breast cancer treated with evidence-based therapy. There is a broad spectrum of non-malignant causes for dermatitis of the nipple during the initial presentation that may delay cancer work-up. This case highlights the MPD work-up and management in the context of a personal history of breast cancer. This unique clinical presentation emphasizes the importance of vigilant cancer surveillance for timely intervention, especially for a presumed cured cancer.
Collapse
Affiliation(s)
- Rimsha J Afzal
- Medical Education, University of Pikeville - Kentucky College of Osteopathic Medicine, Pikeville, USA
| | - Mustafa M Basree
- Radiation Oncology, University of Wisconsin School of Medicine and Public Health, Madison, USA
| | - Steven P Howard
- Radiation Oncology, University of Wisconsin School of Medicine and Public Health, Madison, USA
| | - Jin Xu
- Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, USA
| | - Lee G Wilke
- Breast Surgery, University of Wisconsin School of Medicine and Public Health, Madison, USA
| | - Bethany M Anderson
- Radiation Oncology, University of Wisconsin School of Medicine and Public Health, Madison, USA
| |
Collapse
|